Literature DB >> 31775016

Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial.

Jon R Konradsen1, Jeanette Grundström2, Laila Hellkvist3, Thi Anh Thu Tran2, Niklas Andersson4, Guro Gafvelin5, M B Gea Kiewiet2, Carl Hamsten2, Jiaqian Tang6, Rebecca V Parkin6, Mohamed H Shamji6, Gunilla Hedlin7, Lars-Olaf Cardell3, Marianne van Hage8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31775016     DOI: 10.1016/j.jaci.2019.11.017

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta-analysis.

Authors:  Nor Rahimah Aini; Norhayati Mohd Noor; Mohd Khairi Md Daud; Sarah K Wise; Baharudin Abdullah
Journal:  Clin Transl Allergy       Date:  2021-08-17       Impact factor: 5.871

2.  Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.

Authors:  Hye Jung Park; Sae-Hoon Kim; Yoo Seob Shin; Chul Hwan Park; Eun-Suk Cho; Seung Joon Choi; So Hyun Park; Joo Hyun Jung; Il Gyu Kang; Myoung Seok Lee; Dae Woo Kim; Sang Min Lee; Min-Suk Yang; Sang Pyo Lee
Journal:  Respir Res       Date:  2021-06-04

Review 3.  Recent Advances in Allergen-Specific Immunotherapy in Humans: A Systematic Review.

Authors:  Sang Pyo Lee; Yoo Seob Shin; Sung-Yoon Kang; Tae-Bum Kim; Sang Min Lee
Journal:  Immune Netw       Date:  2022-02-07       Impact factor: 5.851

Review 4.  Allergen immunotherapy: past, present and future.

Authors:  Stephen R Durham; Mohamed H Shamji
Journal:  Nat Rev Immunol       Date:  2022-10-17       Impact factor: 108.555

5.  Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen.

Authors:  Lars Ahlbeck; Emelie Ahlberg; Janne Björkander; Caroline Aldén; Georgia Papapavlou; Laura Palmberg; Ulla Nyström; Pavlos Retsas; Patrik Nordenfelt; Totte Togö; Pål Johansen; Bo Rolander; Karel Duchén; Maria C Jenmalm
Journal:  Clin Exp Allergy       Date:  2022-04-01       Impact factor: 5.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.